Sseug Ssagcream

Xanthium Strumarium Fruit Extract, Canavalia Gladiata Extract


S-one Pharmaceutical Inc
Human Otc Drug
NDC 74721-0100
Sseug Ssagcream also known as Xanthium Strumarium Fruit Extract, Canavalia Gladiata Extract is a human otc drug labeled by 'S-one Pharmaceutical Inc'. National Drug Code (NDC) number for Sseug Ssagcream is 74721-0100. This drug is available in dosage form of Cream. The names of the active, medicinal ingredients in Sseug Ssagcream drug includes Canavalia Gladiata Whole - 5 g/100mL Xanthium Strumarium Fruit - 10 g/100mL . The currest status of Sseug Ssagcream drug is Active.

Drug Information:

Drug NDC: 74721-0100
The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
Proprietary Name: Sseug Ssagcream
Also known as the trade name. It is the name of the product chosen by the labeler.
Product Type: Human Otc Drug
Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing.
Non Proprietary Name: Xanthium Strumarium Fruit Extract, Canavalia Gladiata Extract
Also known as the generic name, this is usually the active ingredient(s) of the product.
Labeler Name: S-one Pharmaceutical Inc
Name of Company corresponding to the labeler code segment of the ProductNDC.
Dosage Form: Cream
The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources.
Status: Active
FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved.
Substance Name:CANAVALIA GLADIATA WHOLE - 5 g/100mL
XANTHIUM STRUMARIUM FRUIT - 10 g/100mL
This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.
Route Details:TOPICAL
The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

Marketing Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Marketing Category: UNAPPROVED DRUG OTHER
Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
Marketing Start Date: 22 Jul, 2022
This is the date that the labeler indicates was the start of its marketing of the drug product.
Marketing End Date: 19 Jun, 2026
This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
Listing Expiration Date: 31 Dec, 2024
This is the date when the listing record will expire if not updated or certified by the firm.

OpenFDA Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Manufacturer Name:S-ONE PHARMACEUTICAL INC
Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC.
Original Packager:Yes
Whether or not the drug has been repackaged for distribution.
UPC:8809091073601
UPC stands for Universal Product Code.
UNII:9PHQ0141AL
TN770YC17C
Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information.

Packaging Information:

Package NDCDescriptionMarketing Start DateMarketing End DateSample Available
74721-0100-130 mL in 1 TUBE (74721-0100-1)22 Jul, 2022N/ANo
Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together.

Purpose:

Purpose hand & feet skin softening product

Product Elements:

Sseug ssagcream xanthium strumarium fruit extract, canavalia gladiata extract petrolatum cetyl alcohol shea butter glycerin canavalia gladiata whole canavalia gladiata whole xanthium strumarium fruit xanthium strumarium fruit olive oil propylene glycol glyceryl stearate se citric acid monohydrate polysorbate 60 yellow wax aloe vera leaf hyaluronic acid water poly-l-lysine (30000-70000 mw)

Indications and Usage:

Directions 1) wash your hands and feet with clean foot soap and use a towel and dryer to completely remove moisture 2) after applying this product thickly to the nails or toenails you want to use, attach it using a gauze or a disposable band to prevent the cream from being lost to the outside.

Warnings:

Warnings for external use only. make sure to close the cap after use.

Do Not Use:

Warnings for external use only. make sure to close the cap after use.

Dosage and Administration:

Use it is a cream made by using xanthium strumarium fruit extract as the main ingredient and helps various skin problems.

Package Label Principal Display Panel:

Package label 74721-0100-1


Comments/ Reviews:

* Data of this site is collected from www.fda.gov. This page is for informational purposes only. Always consult your physician with any questions you may have regarding a medical condition.